Profil
Anthony Dyer served as Director & Chief Corporate Development Officer at Novacyt SAS from 2021 to 2021.
Prior to that, he was Director at Microgen Bioproducts Ltd. from 2014 to 2021.
He will serve as CFO & Non-Executive Director at Love Hemp Group Plc from 2022 to 2023.
Dyer completed his undergraduate degree at the University of East Anglia.
Anciens postes connus de Anthony Dyer
| Sociétés | Poste | Fin |
|---|---|---|
Love Hemp Group Plc
Love Hemp Group Plc Financial ConglomeratesFinance Invests in medical cannabis industry | Directeur Financier/CFO | 20/01/2023 |
| NOVACYT | Directeur Financier/CFO | 05/01/2021 |
Microgen Bioproducts Ltd.
Microgen Bioproducts Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and distributes diagnostic products for clinical, food, industrial veterinary and environmental testing | Directeur/Membre du Conseil | 01/04/2021 |
Formation de Anthony Dyer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of East Anglia
University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novacyt SAS
Novacyt SAS Medical SpecialtiesHealth Technology Designs, develops and markets molecular real-time PCR testing devices and reagents in the areas of infectious diseases | Health Technology |
Microgen Bioproducts Ltd.
Microgen Bioproducts Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and distributes diagnostic products for clinical, food, industrial veterinary and environmental testing | Electronic Technology |
Love Hemp Group Plc
Love Hemp Group Plc Financial ConglomeratesFinance Invests in medical cannabis industry | Finance |
















